▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2 by analyst upside · 2026-09-09
SLXN
Silexion Therapeutics Corp
Healthcare · Market Cap $2M · P/E 0x
ANALYST PRICE TARGET
+17296.3%
implied upside to consensus target
Current Price $0.34
Consensus Target $60.0
Bull Target $60.0
Bear Target $60.0
Analysts Covering 1
ANALYST CONSENSUS - UNDERPERFORM
Strong Buy
0
Buy
0
Hold
0
Sell
1
52-Week Low $0.34
52-Week High $77.7
YTD Return -98.2%
FUNDAMENTALS
Market Cap $2M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-19.89
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.34
52-Week High $77.7
Current Price $0.34
Bear Target $60.0
Bull Target $60.0
● Now $0.34 ● Target $60.0
TRADING DATA
Avg Volume 293K
YTD Return -98.2%
Analyst Count 1
Consensus Underperform
Upside to Target +17296.3%
Last Updated 2026-09-09

ANALYST SUMMARY

Silexion Therapeutics Corp (SLXN) is currently trading at $0.34 with a Wall Street consensus price target of $60.0, implying potential upside of 17296.3% over the next 12 months. 1 analysts currently cover SLXN, with a consensus rating of Underperform - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $60.0, while the most cautious has a target of $60.0.

SLXN operates in the Healthcare sector with a market capitalisation of $2M. The stock is down 98.2% year-to-date and is currently trading near the lower end of its 52-week range of $0.34 – $77.7.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CRIS +3259.6%
Curis, Inc.
$3M · P/E 0.3x · Buy
MBRX +1499.8%
Moleculin Biotech, Inc.
$15M · P/E 0.1x · Buy
CNSY +1233.3%
Cerenome, Inc.
$20M · P/E 0.9x · Buy
ETST +1011.1%
Earth Science Tech, Inc.
$26M · P/E 9.0x · Hold
TOVX +911.7%
Theriva Biologics, Inc.
$11M · P/E 0.2x · Strong Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for SLXN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Litchfield Hills ● Initiated
Buy 2025-12-15 0% win rate (6 calls)
Maxim Group - Reiterated
Buy → Buy 2025-03-20 28% win rate (40 calls)
Maxim Group ● Initiated
Buy 2024-11-01 28% win rate (40 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
15
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →